Trial Profile
A randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of once monthly inbandronate in the prevention of glucocorticoid-induced osteoporosis in postmenopausal women (ML20088).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Aug 2012
Price :
$35
*
At a glance
- Drugs Ibandronic acid (Primary) ; Calcium carbonate; Vitamin D analogues
- Indications Menopause; Osteoporosis; Rheumatic disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors Roche
- 31 May 2011 New trial record